OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metformin inhibits hepatocellular carcinoma development by inducing apoptosis and pyroptosis through regulating FOXO3
Zetian Shen, Han Zhou, Ao‐Mei Li, et al.
Aging (2021) Vol. 13, Iss. 18, pp. 22120-22133
Open Access | Times Cited: 42
Zetian Shen, Han Zhou, Ao‐Mei Li, et al.
Aging (2021) Vol. 13, Iss. 18, pp. 22120-22133
Open Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 85
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 85
Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance
Xudong Zhu, Shenglong Li
Advanced Science (2023) Vol. 10, Iss. 26
Open Access | Times Cited: 44
Xudong Zhu, Shenglong Li
Advanced Science (2023) Vol. 10, Iss. 26
Open Access | Times Cited: 44
Pyroptosis in health and disease: mechanisms, regulation and clinical perspective
Yifan Liu, Renjie Pan, Yuzhen Ouyang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 37
Yifan Liu, Renjie Pan, Yuzhen Ouyang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 37
Crosstalk between metabolism and cell death in tumorigenesis
Shichao Yang, Caden Hu, Xiaomei Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Shichao Yang, Caden Hu, Xiaomei Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 26
FOXO3a in cancer drug resistance
Ying Liu, Yu Wang, Xiaoge Li, et al.
Cancer Letters (2022) Vol. 540, pp. 215724-215724
Closed Access | Times Cited: 54
Ying Liu, Yu Wang, Xiaoge Li, et al.
Cancer Letters (2022) Vol. 540, pp. 215724-215724
Closed Access | Times Cited: 54
GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis
Tianxing Chen, Meng Yao, Zhihang Zhou, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 7, pp. 1829-1848
Closed Access | Times Cited: 36
Tianxing Chen, Meng Yao, Zhihang Zhou, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 7, pp. 1829-1848
Closed Access | Times Cited: 36
The role of pyroptosis in hepatocellular carcinoma
Zhimiao Zou, Minghui Zhao, Yang Yang, et al.
Cellular Oncology (2023) Vol. 46, Iss. 4, pp. 811-823
Closed Access | Times Cited: 28
Zhimiao Zou, Minghui Zhao, Yang Yang, et al.
Cellular Oncology (2023) Vol. 46, Iss. 4, pp. 811-823
Closed Access | Times Cited: 28
Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy
Y. Qin, Shisong Han, Yahan Yu, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1808-1831
Closed Access | Times Cited: 14
Y. Qin, Shisong Han, Yahan Yu, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1808-1831
Closed Access | Times Cited: 14
A novel pharmacological mechanism of anti-cancer drugs that induce pyroptosis
Haohao Guo, Ziyang Wang, Runsheng Ma, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 745-754
Open Access | Times Cited: 19
Haohao Guo, Ziyang Wang, Runsheng Ma, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 745-754
Open Access | Times Cited: 19
The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3161-3161
Open Access | Times Cited: 19
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3161-3161
Open Access | Times Cited: 19
Quercetin Alleviates the Progression of Breast Cancer-Related Depression via Inhibiting the Pyroptosis and Promoting the Immune Response
Qing Zhu, Lei Yang, Hui Yang, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 25
Qing Zhu, Lei Yang, Hui Yang, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 25
Role of NLRP3 inflammasome in hepatocellular carcinoma: A double-edged sword
Yingle Tang, Tao Yan, Lin Zhu, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110107-110107
Closed Access | Times Cited: 16
Yingle Tang, Tao Yan, Lin Zhu, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110107-110107
Closed Access | Times Cited: 16
Pyroptosis: shedding light on the mechanisms and links with cancers
Hong‐mei You, Ling Wang, Hongwu Meng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Hong‐mei You, Ling Wang, Hongwu Meng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Synergistic apoptosis by combination of metformin and an O-GlcNAcylation inhibitor in colon cancer cells
Da Eun Lee, Geun Yong Lee, Hae Min Lee, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Da Eun Lee, Geun Yong Lee, Hae Min Lee, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Advances in Targeted Drug Resistance Associated with Dysregulation of Lipid Metabolism in Hepatocellular Carcinoma
Xiaoju Huang, Mengmeng Wang, Dan Zhang, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 113-129
Open Access | Times Cited: 5
Xiaoju Huang, Mengmeng Wang, Dan Zhang, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 113-129
Open Access | Times Cited: 5
Ferroptosis, pyroptosis and necroptosis in hepatocellular carcinoma immunotherapy: Mechanisms and immunologic landscape (Review)
Ruijia Liu, Xudong Yu, Shao-Shuai Yan, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 6
Open Access | Times Cited: 5
Ruijia Liu, Xudong Yu, Shao-Shuai Yan, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 6
Open Access | Times Cited: 5
The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity
Stavros P. Papadakos, Nikolaos Dedes, Elias Kouroumalis, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3150-3150
Open Access | Times Cited: 19
Stavros P. Papadakos, Nikolaos Dedes, Elias Kouroumalis, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3150-3150
Open Access | Times Cited: 19
Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering AKT‐FOXO3 signalling pathway
Yizhe Cheng, Ping Zhan, Jing Lü, et al.
Liver International (2023) Vol. 43, Iss. 7, pp. 1577-1592
Closed Access | Times Cited: 11
Yizhe Cheng, Ping Zhan, Jing Lü, et al.
Liver International (2023) Vol. 43, Iss. 7, pp. 1577-1592
Closed Access | Times Cited: 11
Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma
Edgar Xchel Franco-Juárez, Vianey González-Villasana, María Elena Camacho-Moll, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1760-1760
Open Access | Times Cited: 4
Edgar Xchel Franco-Juárez, Vianey González-Villasana, María Elena Camacho-Moll, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1760-1760
Open Access | Times Cited: 4
Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK/JNK/IL-8 pathway
Chengwen Zhao, Lu Zheng, Yuting Ma, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 4
Chengwen Zhao, Lu Zheng, Yuting Ma, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 4
NLRP3 inflammasomes pathway: a key target for Metformin
Yasamin Hosseini, Amirhossein Niknejad, Ayeh Sabbagh Kashani, et al.
Inflammopharmacology (2025)
Closed Access
Yasamin Hosseini, Amirhossein Niknejad, Ayeh Sabbagh Kashani, et al.
Inflammopharmacology (2025)
Closed Access
The Regulatory Role of NcRNAs in Pyroptosis and Disease Pathogenesis
Shaocong Wang, Xinzhe Chen, Kun Wang, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Shaocong Wang, Xinzhe Chen, Kun Wang, et al.
Cell Biochemistry and Biophysics (2025)
Closed Access
Comprehensive Analysis of the Correlation Between Pyroptosis-Related LncRNAs and Tumor Microenvironment, Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
Guangzhen Qu, Dong Wang, Weiyu Xu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 17
Guangzhen Qu, Dong Wang, Weiyu Xu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 17
The role of NLRP3 inflammasome in hepatocellular carcinoma
Huijie Zhao, Yiming Zhang, Yanting Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Huijie Zhao, Yiming Zhang, Yanting Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Shuanghua decoction exerts anticancer activity by activating NLRP3 inflammasome via ROS and inhibiting NF-κB signaling in hepatocellular carcinoma cells
Bingling Dai, Mengying Fan, Xiaoyue Huang, et al.
Phytomedicine (2022) Vol. 103, pp. 154249-154249
Closed Access | Times Cited: 15
Bingling Dai, Mengying Fan, Xiaoyue Huang, et al.
Phytomedicine (2022) Vol. 103, pp. 154249-154249
Closed Access | Times Cited: 15
